Trials / Completed
CompletedNCT05009914
A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG.
Assessing a New Way of Cardiac Denervation to Reduce the Incidence of Atrial Fibrillation After Coronary Artery Bypass Grafting.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 430 (actual)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, random controlled trial(RCT) study. 430 patients undergoing coronary artery bypass grafting were enrolled. Our new way of cardiac denervation, defined as excision of Marshall ligament and Waterstone fat pad, was performed in 215 patients, and the other 215 patients were used as control subjects. All the patients need to equip with electronic monitor to record heart rhythms within 6 days after CABG. The investigators will compare the incidence of postoperative atrial fibrillation between two groups, and follow up 30 days after discharged.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cardiac denervation | Excision of Marshall ligament and Waterstone fat pad during CABG. |
Timeline
- Start date
- 2022-08-15
- Primary completion
- 2023-12-13
- Completion
- 2024-01-30
- First posted
- 2021-08-18
- Last updated
- 2024-05-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05009914. Inclusion in this directory is not an endorsement.